In conclusion, current studies suggest that AQP3 may act as an important target for disorders that involve disruption of intestinal fluid homeostasis like diarrhea, constipation, inflammatory bowel disease and irritable bowel syndrome. The gene discussed is AQP3; the disease is inflammatory bowel disease.